S. Louise Phanstiel bought $466K of Myriad Genetics (MYGN)

Executed Feb 26, disclosed Feb 27, 1 day later.

Value, as filed

$466K

98,407 sh across 2 lots

Executed

Feb 26

the trade date, as filed

Disclosed

Feb 27

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-10.3%

-4.1% from execution

Over the 21 trading sessions from the disclosed entry session (Feb 27), the stock returned -10.3% (delay-adjusted); from the execution session (Feb 26), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

S. Louise Phanstiel Director profile →

S. Louise Phanstiel (Director) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales), most often in Butterfly Network, Inc. (BFLY). Across 3 priced purchase filings, the average 21-session return was +15.1% from execution and +0.8% from disclosure (delay-adjusted; derived). The largest single filing was $1000K of BFLY (115,200 sh × $8.68, as filed), executed Aug 14.

The name

MYGN MYGN MYGN · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→